Was the obesity crisis actually manufactured by a $36 billion food marketing industry?
Stop blaming willpower. Learn how a $36 billion food marketing system hijacked our biology and why GLP-1 drugs like Ozempic are the inevitable response.
Key Takeaways
What: Semaglutide is a lab-synthesized peptide that regulates hunger and insulin.
Why: It counters a $36 billion food industry specifically designed to bypass human willpower.
How: The drug creates an “inner silence,” treating obesity as a biochemical disease rather than a character flaw.
The obesity epidemic is often framed as a modern failure of willpower, but the numbers tell a different story. Between 1976 and 2006, the number of obese adults in the U.S. rose exponentially, eventually reaching 30 percent. By 2023, more than 70 percent of American adults were classified as either overweight or obese. While we often blame individual choices, the reality is that our collective biology was hijacked by a massive, $36 billion industrial initiative designed to make us eat more.
The $36 Billion Appetite
In the 1980s, the food industry underwent a massive shift. Large brands like Kellogg’s and Kraft began to lean into a trend of “abundance” in their marketing. They realized that as two-income households became the norm and microwaves found their way into every kitchen, there was a goldmine in convenience. The goal wasn’t just to provide food, but to sell ultra-processed meals and packaged snacks that could be prepared in seconds.
By 1994, the U.S. Department of Agriculture estimated that food companies were spending $36 billion a year on advertising. This wasn’t just about brand awareness; it was an intentional effort to encourage higher consumption. These ads often highlighted added vitamins while ignoring the heavy presence of salts, stabilizers, emulsifiers, and sugars. Soft drink giants spent billions lobbying to keep their products in schools, and cereal boxes were redesigned with bright cartoon characters to appeal directly to children. One serving of a typical sweetened puffed-wheat cereal was found to contain as much sugar as a Snickers bar. By the time portions began to balloon—like McDonald’s “large” fries becoming the equivalent of their old “supersized” portion—the environment was perfectly tuned to drive weight gain across every level of society.
The Willpower Myth
For decades, the medical response to this manufactured crisis was a tired script: “eat less, exercise more”. Patients who struggled with their weight were often met with judgment rather than care. They described a “cloak of shame,” where every health complaint was dismissed by doctors who told them their only problem was a lack of self-control.
This narrative ignored the biochemical reality that appetite is largely controlled by hormones rather than character. While society peddled the idea of gluttony, researchers were beginning to see obesity as a disease of the gut-brain connection. They found that hormones like leptin and GLP-1 (glucagon-like peptide-1) were the actual managers of hunger and fullness. If these hormones were out of balance, no amount of willpower could silence the biological drive to eat.
The Race to Synthesize a Solution
The path to a pharmaceutical fix began in 1972 when Svetlana Mojsov, a biochemist from the former Yugoslavia, arrived at Rockefeller University in New York. She focused on studying glucagon, a hormone that affects blood sugar, and eventually pioneered a method for synthesizing large quantities of protein molecules known as peptides.
By the mid-1980s, Mojsov’s work at Massachusetts General Hospital led to the identification of GLP-1 in the gut. Working alongside other researchers, she confirmed that this specific molecule could trigger the release of insulin. However, there was a major hurdle: the human body has enzymes that destroy natural GLP-1 almost immediately, making it useless as a direct injection.
The breakthrough came from an unlikely place: the venom of a Gila Monster. In 1990, biochemist John Eng found that a molecule in the lizard’s venom acted like GLP-1 but remained stable for much longer. This discovery set off a race among pharmaceutical giants. While early versions of the drug required twice-daily injections, scientists at Novo Nordisk, like Lotte Bjerre Knudsen, worked to create a version that lasted even longer. This effort resulted in semaglutide, the molecule known today as Ozempic.
The Arrival of the Weekly Injection
Ozempic hit the U.S. market in 2018, originally designed for Type 2 diabetes management. However, its weight-loss effects were impossible to ignore. In clinical trials, users taking semaglutide lost between 17 and 18 percent of their body weight, compared to the 2 to 3 percent typically seen in standard dieting.
For many users, the most striking change isn’t on the scale, but in their heads. Patients describe an “inner silence”—a sudden end to the constant, lifelong obsession with what and when they would eat next. The drug effectively quiets the noise that the $36 billion food marketing machine had spent decades amplifying.
The Weight of the Side Effects
Despite the success, this pharmaceutical fix comes with significant risks. Semaglutide works by slowing down digestion and stomach emptying, which can cause severe nausea and vomiting. In some cases, the effect is so powerful that it leads to gastric paresis—a permanent paralysis of the stomach. Other patients have required partial or full colostomies due to the drug’s impact on their digestive tract.
There is also the cultural cost. The surge in demand has fueled a black market where people chasing an extreme “skinny ideal” risk using counterfeit versions of the drug. This has led to cases of malnutrition, organ failure, and even death among those with body dysmorphia.
The rise of semaglutide is reshaping how we view metabolism and health. It has exposed the fact that our modern obesity crisis was a corporate creation rather than a personal failing. But while a weekly injection can silence the hunger, it cannot fix the systemic food environment that made the drug necessary in the first place. We are now living in a society that is literally injecting its way out of a problem that it spent billions of dollars to create.